Accel Research Sites lead investigator discusses latest information regarding new omicron variant with local Orlando station - Alcanza Clinical Research

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 11/30/2021

Accel Research Sites lead investigator discusses latest information regarding new omicron variant with local Orlando station

Dr. Bruce Rankin has been working on COVID-19 clinical trials since the beginning of the pandemic.

As more variants start to emerge including the latest omicron variant, Dr. Rankin shares his expertise on what we can expect in terms of vaccination timelines and what this means for the community.

To learn more, click here.

Back

Articles

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height